• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持-间质细胞瘤

Sertoli-Leydig cell tumor.

作者信息

Lantzsch T, Stoerer S, Lawrenz K, Buchmann J, Strauss H G, Koelbl H

机构信息

Department of Gynecology, Martin-Luther-University, Halle-Wittenberg, Halle/Saale, Germany.

出版信息

Arch Gynecol Obstet. 2001 Jan;264(4):206-8. doi: 10.1007/s004040000114.

DOI:10.1007/s004040000114
PMID:11205710
Abstract

Sertoli-Leydig cell tumors belong to the group of sex-cord stromal tumors of the ovary. They account for less than 0,5% of all ovarian neoplasms. The majority of these tumors are benign, and almost all are localised unilaterally. Herewith, we describe an ovarian Sertoli-Leydig cell tumor in an 11-year-old girl. Serum levels of estradiol and progesterone were mildly elevated. while testosterone and androstendion levels were raised to around three- and sevenfold upper normal limit respectively on presentation. A left salpingo-oophorectomy was performed. Microscopically, the tumor was intermediately differentiated. At 6 months follow-up, there was neither clinical nor sonographical evidence of recurrence, and almost all sex hormone levels had returned to within normal range. Treatment of this pathological entity has to be individualized according to patient age, stage of tumor and degree of differentiation.

摘要

支持-间质细胞瘤属于卵巢性索间质肿瘤。它们占所有卵巢肿瘤的比例不到0.5%。这些肿瘤大多数是良性的,几乎所有肿瘤都单侧局限。在此,我们描述一名11岁女孩的卵巢支持-间质细胞瘤。血清雌二醇和孕酮水平轻度升高,而睾酮和雄烯二酮水平在初诊时分别升高至正常上限的约三倍和七倍。进行了左侧输卵管卵巢切除术。显微镜下,肿瘤为中度分化。随访6个月时,既无临床证据也无超声证据显示复发,几乎所有性激素水平已恢复至正常范围。这种病理实体的治疗必须根据患者年龄、肿瘤分期和分化程度个体化。

相似文献

1
Sertoli-Leydig cell tumor.支持-间质细胞瘤
Arch Gynecol Obstet. 2001 Jan;264(4):206-8. doi: 10.1007/s004040000114.
2
Bilateral Sertoli-Leydig cell tumor of the ovary: a rare case report.双侧卵巢支持-间质细胞瘤:一例罕见病例报告
Indian J Pathol Microbiol. 2009 Jan-Mar;52(1):97-9. doi: 10.4103/0377-4929.44981.
3
Sertoli-Leydig cell tumor: a rare ovarian neoplasm. Case report and review of literature.支持-间质细胞瘤:一种罕见的卵巢肿瘤。病例报告及文献复习
Gynecol Endocrinol. 2008 Apr;24(4):230-4. doi: 10.1080/09513590801953465.
4
Direct laparoscopic venous sampling to diagnose a small Sertoli-Leydig tumor.直接腹腔镜静脉采血以诊断小的支持-间质细胞瘤。
Gynecol Oncol. 2003 Oct;91(1):254-7. doi: 10.1016/s0090-8258(03)00405-0.
5
Retiform Sertoli-Leydig cell tumor of ovary in a 9-year-old girl: case report and review of the literature.卵巢网织状支持-间质细胞瘤 9 岁女童 1 例并文献复习
Int J Clin Oncol. 2011 Dec;16(6):705-8. doi: 10.1007/s10147-011-0186-6. Epub 2011 Feb 24.
6
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.以异源性胃肠道上皮为甲胎蛋白来源的卵巢支持-间质细胞瘤:一例报告
J Obstet Gynaecol Res. 2008 Jun;34(3):418-21. doi: 10.1111/j.1447-0756.2008.00730.x.
7
Immunohistochemical and biochemical analysis of a human Sertoli-Leydig cell tumor: autonomous steroid production characteristic of ovarian theca cells.人支持-间质细胞瘤的免疫组织化学和生化分析:具有卵巢卵泡膜细胞自主性甾体激素分泌特征
J Soc Gynecol Investig. 1995 Jan-Feb;2(1):30-7.
8
[Poorly differentiated Sertoli-Leydig cell tumor of the ovary: imaging with pathologic correlations. A case report].[卵巢低分化支持-莱迪希细胞瘤:影像表现与病理对照。病例报告]
Radiol Med. 2001 Sep;102(3):192-4.
9
Sertoli-Leydig cell tumor in a 12-year-old girl: a review article and case report.一名12岁女孩的支持-间质细胞瘤:一篇综述文章及病例报告
Arch Gynecol Obstet. 2014 Oct;290(4):791-6. doi: 10.1007/s00404-014-3293-6. Epub 2014 Jun 11.
10
Recurrent Sertoli-Leydig cell tumor of ovary in 8-year-old girl.8岁女孩复发性卵巢支持-间质细胞瘤
Scott Med J. 2016 Feb;61(1):56-9. doi: 10.1177/0036933015619297. Epub 2016 Jun 22.

引用本文的文献

1
Successful management of Leydig Cell Tumor in a 65-year-Old patient: A rare case report.65岁患者睾丸间质细胞瘤的成功治疗:一例罕见病例报告
Urol Case Rep. 2025 Jan 2;58:102927. doi: 10.1016/j.eucr.2024.102927. eCollection 2025 Jan.
2
Validation of a deep neural network-based algorithm supporting clinical management of adnexal mass.基于深度神经网络的算法在附件包块临床管理中的验证
Front Med (Lausanne). 2023 Jan 23;10:1102437. doi: 10.3389/fmed.2023.1102437. eCollection 2023.
3
Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
卵巢 Sertoli-Leydig 细胞肿瘤 (SLCT) 的特征和结局分析:15 例患者分析。
J Ovarian Res. 2021 Nov 4;14(1):150. doi: 10.1186/s13048-021-00909-7.
4
Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman.卵巢睾丸间质细胞瘤:绝经后女性男性化的原因。
Am J Case Rep. 2021 Aug 27;22:e933126. doi: 10.12659/AJCR.933126.
5
Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and Mutations: Case Report and Literature Review.卵巢支持-间质细胞瘤、结节性甲状腺肿、囊性肾瘤与突变:病例报告及文献综述
Pharmgenomics Pers Med. 2021 Aug 3;14:947-953. doi: 10.2147/PGPM.S317153. eCollection 2021.
6
Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary.采用腹腔内热灌注化疗和胸腔内热灌注化疗对卵巢转移性支持-间质细胞瘤进行肿瘤细胞减灭术。
Gynecol Oncol Rep. 2020 Sep 6;34:100638. doi: 10.1016/j.gore.2020.100638. eCollection 2020 Nov.
7
Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.卵巢支持-间质细胞瘤:流行病学、临床及预后因素
Rev Bras Ginecol Obstet. 2019 Jul;41(7):440-448. doi: 10.1055/s-0039-1693056. Epub 2019 Jul 25.
8
Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.减瘤手术及腹腔内热灌注化疗的罕见适应证
Pleura Peritoneum. 2017 Sep 1;2(3):129-136. doi: 10.1515/pp-2017-0017. Epub 2017 Aug 24.
9
Sertoli-Leydig Cell Tumor of Ovary: A Rare Case Report with Heterologous Elements and Focal Marked Anaplasia.卵巢支持-间质细胞瘤:1例伴有异源成分和局灶性显著间变的罕见病例报告
Int J Appl Basic Med Res. 2019 Jan-Mar;9(1):62-64. doi: 10.4103/ijabmr.IJABMR_84_18.
10
A Rare Case of Intra-Endometrial Leiomyoma of Uterus Simulating Degenerated Submucosal Leiomyoma Accompanied by a Large Sertoli-Leydig Cell Tumor.子宫内膜内平滑肌瘤模拟退化性黏膜下平滑肌瘤伴大的支持-间质细胞瘤1例罕见病例
Yonsei Med J. 2016 Mar;57(2):523-6. doi: 10.3349/ymj.2016.57.2.523.